there is the change, and its sustained
The Medicines and Healthcare products Regulatory Agency (MHRA) in the UK has licensed a number of GLP-1 and GIP drugs, such as Wegovy (semaglutide) and Mounjaro (tirzepatide)

if you have diabetes and take insulin or sulfonylureas, monitor for hypoglycaemia and discuss potential dose adjustments with your healthcare provider Hyponatraemia : SSRIs like escitalopram have been associated with low sodium levels, particularly in older adults or those taking diuretics Gallbladder disease : Semaglutide is associated with increased risk of gallstones and cholecystitis Kidney function : Severe vomiting or diarrhoea from Wegovy can lead to dehydration and acute kidney injury Diabetic retinopathy : For people with diabetes and pre-existing diabetic retinopathy, semaglutide requires ophthalmic monitoring Rare but serious effects requiring immediate medical attention include: Signs of pancreatitis (severe abdominal pain radiating to the back) Symptoms of serotonin syndrome (agitation, confusion, rapid heart rate, muscle rigidity) Severe allergic reactions Persistent vomiting leading to dehydration Maintaining a symptom diary can help you and your healthcare provider identify patterns and adjust treatment as needed

3- Better sleep and cellular repair: GH plays a significant role in deep sleep and cellular regeneration
Strategies to manage them include starting with a low dose and gradually increasing, eating smaller, more frequent meals, avoiding fatty foods, and staying well-hydrated